Giuseppe Ciaramella, President & CSO at Beam Therapeutics Inc. (BEAM), sold 7,344 shares at $29.09 ($218K) on 2023-04-04, disclosed to the SEC on 2023-04-05.
Scheduled sale ($218k) by President & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.31 | 1,918 | $58K | 26.6% |
| 2 | $30.31 | 1,918 | $58K | 26.6% |
| 3 | $29.09 | 1,754 | $51K | 23.4% |
| 4 | $29.09 | 1,754 | $51K | 23.4% |
| Total | $29.73 avg | 7,344 | $218K | 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |